Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZW) EBIT (2020 - 2025)

Core Scientific (CORZW) has disclosed EBIT for 6 consecutive years, with -$117.5 million as the latest value for Q4 2025.

  • Quarterly EBIT fell 79.65% to -$117.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$245.6 million through Dec 2025, down 72.87% year-over-year, with the annual reading at -$245.6 million for FY2025, 72.87% down from the prior year.
  • EBIT hit -$117.5 million in Q4 2025 for Core Scientific, down from -$54.8 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of $102.2 million in Q4 2021 to a low of -$1.0 billion in Q2 2022.
  • Historically, EBIT has averaged -$117.8 million across 5 years, with a median of -$26.5 million in 2022.
  • Biggest five-year swings in EBIT: surged 982388.46% in 2021 and later crashed 8489.92% in 2022.
  • Year by year, EBIT stood at $102.2 million in 2021, then crashed by 722.64% to -$636.1 million in 2022, then soared by 100.62% to $3.9 million in 2023, then crashed by 1762.2% to -$65.4 million in 2024, then plummeted by 79.65% to -$117.5 million in 2025.
  • Business Quant data shows EBIT for CORZW at -$117.5 million in Q4 2025, -$54.8 million in Q3 2025, and -$26.3 million in Q2 2025.